Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 22392450)

1.

Distinct roles for complement in glomerulonephritis and atherosclerosis revealed in mice with a combination of lupus and hyperlipidemia.

Lewis MJ, Malik TH, Fossati-Jimack L, Carassiti D, Cook HT, Haskard DO, Botto M.

Arthritis Rheum. 2012 Aug;64(8):2707-18. doi: 10.1002/art.34451.

2.

Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus.

Stanic AK, Stein CM, Morgan AC, Fazio S, Linton MF, Wakeland EK, Olsen NJ, Major AS.

Proc Natl Acad Sci U S A. 2006 May 2;103(18):7018-23. Epub 2006 Apr 24.

3.

The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.

Malik TH, Cortini A, Carassiti D, Boyle JJ, Haskard DO, Botto M.

Circulation. 2010 Nov 9;122(19):1948-56. doi: 10.1161/CIRCULATIONAHA.110.981365. Epub 2010 Oct 25. Erratum in: Circulation. 2011 Dec 6;124(23):e781.

4.

Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice.

Braun Na, Wade NS, Wakeland EK, Major AS.

Lupus. 2008 Dec;17(12):1070-8. doi: 10.1177/0961203308093551.

5.

Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.

Sekine H, Reilly CM, Molano ID, Garnier G, Circolo A, Ruiz P, Holers VM, Boackle SA, Gilkeson GS.

J Immunol. 2001 May 15;166(10):6444-51.

6.

Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.

Lewis MJ, Malik TH, Ehrenstein MR, Boyle JJ, Botto M, Haskard DO.

Circulation. 2009 Aug 4;120(5):417-26. doi: 10.1161/CIRCULATIONAHA.109.868158. Epub 2009 Jul 20.

7.

The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice.

Wade NS, Stevenson BG, Dunlap DS, Major AS.

Lupus. 2010 Jan;19(1):34-42. doi: 10.1177/0961203309345785. Epub 2009 Oct 22.

8.

17-β Estradiol reduces atherosclerosis without exacerbating lupus in ovariectomized systemic lupus erythematosus-susceptible LDLr(-/-) mice.

Shelton KA, Cline JM, Cann JA.

Atherosclerosis. 2013 Apr;227(2):228-35. doi: 10.1016/j.atherosclerosis.2012.12.031. Epub 2013 Jan 18.

9.

Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway.

Recinos A 3rd, Carr BK, Bartos DB, Boldogh I, Carmical JR, Belalcazar LM, Brasier AR.

Physiol Genomics. 2004 Sep 16;19(1):131-42. Epub 2004 Jul 6.

10.

RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.

Sun L, Ishida T, Yasuda T, Kojima Y, Honjo T, Yamamoto Y, Yamamoto H, Ishibashi S, Hirata K, Hayashi Y.

Cardiovasc Res. 2009 May 1;82(2):371-81. doi: 10.1093/cvr/cvp036. Epub 2009 Jan 28.

11.
12.

Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow.

Baldán A, Pei L, Lee R, Tarr P, Tangirala RK, Weinstein MM, Frank J, Li AC, Tontonoz P, Edwards PA.

Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2301-7. Epub 2006 Aug 3.

13.

Group 1B phospholipase A₂ inactivation suppresses atherosclerosis and metabolic diseases in LDL receptor-deficient mice.

Hollie NI, Konaniah ES, Goodin C, Hui DY.

Atherosclerosis. 2014 Jun;234(2):377-80. doi: 10.1016/j.atherosclerosis.2014.03.027. Epub 2014 Apr 1.

14.

Brief report: accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59.

Yun S, Leung VW, Botto M, Boyle JJ, Haskard DO.

Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1714-6. doi: 10.1161/ATVBAHA.108.169912. Epub 2008 Jul 10.

15.

Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.

Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, Khami M, Koppes JB, Sawyez CG, Whitman SC, Huff MW.

Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):742-8. doi: 10.1161/ATVBAHA.109.201095. Epub 2010 Jan 28.

17.

Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice.

Gautier EL, Huby T, Ouzilleau B, Doucet C, Saint-Charles F, Gremy G, Chapman MJ, Lesnik P.

Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1625-31. Epub 2007 Apr 19.

18.

Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.

van Leuven SI, Mendez-Fernandez YV, Wilhelm AJ, Wade NS, Gabriel CL, Kastelein JJ, Stroes ES, Tak PP, Major AS.

Ann Rheum Dis. 2012 Mar;71(3):408-14. doi: 10.1136/annrheumdis-2011-200071. Epub 2011 Sep 27.

19.
20.

Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice.

Bhatia VK, Yun S, Leung V, Grimsditch DC, Benson GM, Botto MB, Boyle JJ, Haskard DO.

Am J Pathol. 2007 Jan;170(1):416-26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk